Literature DB >> 14680412

Overview of partial compliance.

Stephen R Marder1.   

Abstract

A substantial proportion of patients with psychiatric and nonpsychiatric chronic illnesses fail to take their medications as prescribed. A number of studies suggest that 50% or more of individuals with schizophrenia are noncompliant with medications at some time during their illness. In most cases, patients are partially compliant, taking only a portion of their prescribed medications. Noncompliance is probably the most important element contributing to relapse in schizophrenia. Factors contributing to the rate of noncompliance include medication side effects, the severity of psychotic symptoms, impaired cognition, and an inadequate understanding of the role of medication for preventing relapse. In addition, both patients and clinicians overestimate patients' compliance. Strategies for managing partial compliance include the treatment of medication side effects, the education of patients about their illness, and the use of long-acting antipsychotic formulations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14680412

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  27 in total

1.  Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review.

Authors:  Prakash S Masand; Miquel Roca; Martin S Turner; John M Kane
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

2.  Partial compliance with antipsychotics increases mental health hospitalizations in schizophrenic patients: analysis of a national managed care database.

Authors:  Chris M Kozma; Peter J Weiden
Journal:  Am Health Drug Benefits       Date:  2009-01

3.  Can a digital medicine system improve adherence to antipsychotic treatment?

Authors:  D Papola; C Gastaldon; G Ostuzzi
Journal:  Epidemiol Psychiatr Sci       Date:  2018-03-12       Impact factor: 6.892

Review 4.  Cognitive impairment as determinant for sub-optimal control of oral anticoagulation treatment in elderly patients with atrial fibrillation.

Authors:  Bob A J van Deelen; Patricia M L A van den Bemt; Toine C G Egberts; Annelies van 't Hoff; Huub A A M Maas
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications.

Authors:  T Scott Stroup; Natalie A Bareis; Robert A Rosenheck; Marvin S Swartz; Joseph P McEvoy
Journal:  J Clin Psychiatry       Date:  2018-11-27       Impact factor: 4.384

6.  Communication about adherence to long-term antipsychotic prescribing: an observational study of psychiatric practice.

Authors:  Alan Quirk; Rob Chaplin; Sarah Hamilton; Paul Lelliott; Clive Seale
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-09-25       Impact factor: 4.328

7.  Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period.

Authors:  Y Barak; I Mirecki; H Y Knobler; Z Natan; D Aizenberg
Journal:  Psychopharmacology (Berl)       Date:  2004-02-04       Impact factor: 4.530

8.  What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders.

Authors:  Subho Chakrabarti
Journal:  World J Psychiatry       Date:  2014-06-22

9.  Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients.

Authors:  Haya Ascher-Svanum; Xiaomei Peng; Douglas Faries; William Montgomery; Peter M Haddad
Journal:  BMC Psychiatry       Date:  2009-07-29       Impact factor: 3.630

10.  Cardiovascular disease risk among the poor and homeless - what we know so far.

Authors:  Charlotte A Jones; Arjuna Perera; Michelle Chow; Ivan Ho; John Nguyen; Shahnaz Davachi
Journal:  Curr Cardiol Rev       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.